Terms: = Lung cancer AND PREX2, 6230420N16Rik, DEPDC2, 80243, ENSG00000046889, FLJ12987, DEP_2, P-REX2 AND Treatment
4 results:
1. Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort.
Shen F; Guo W; Song X; Wang B
Diagn Pathol; 2023 Jun; 18(1):71. PubMed ID: 37301854
[TBL] [Abstract] [Full Text] [Related]
2. Molecular and Clinicopathological Characteristics of lung cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).
Ma H; Zhang Q; Zhao Y; Zhang Y; Zhang J; Chen G; Tan Y; Zhang Q; Duan Q; Sun T; Qi C; Li F
Int J Chron Obstruct Pulmon Dis; 2022; 17():1601-1612. PubMed ID: 35860812
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
[TBL] [Abstract] [Full Text] [Related]
4. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model.
Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077
[TBL] [Abstract] [Full Text] [Related]
